Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
New breast cancer research from J.E. Mortimer and co-researchers described
November 5th, 2007
According to recent research published in the journal Clinical Breast Cancer, ": The purpose of this study was to determine the incidence of metastatic bone disease (MBD), the frequency of intravenous (I.V) bisphosphonate use and its impact on skeletal-related events (SREs), and opioid use. Patients diagnosed with MBD between 2000 and 2004 were identified using 2 Thomson MarketScon (R) Research Databases. A total of 6783 patients, 1431 with breast cancer, fulfilled the criteria." "Pain was assessed as the number of days on opioids, the strength of which was categorized according to the World Health Organization 3-step ladder for pain. Use of IN bisphosphonates...
Source: Health & Medicine Week (2007-11-05)
|
